SCHEMBL4875787

SCHEMBL4875787

C=CC1=CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14096765 0.79 TSHR (0.35)
SCHEMBL9498303 0.76
SCHEMBL11081134 0.76
SCHEMBL7827160 0.71
SCHEMBL14311963 0.70 TSHR (0.47)
SCHEMBL12074531 0.69 GABRP (0.32)
SCHEMBL12043319 0.69 CHRM2 (0.42)
SCHEMBL9499563 0.69 CHRM2 (0.42)
SCHEMBL8057972 0.67 HTR2C (0.59)
SCHEMBL7815577 0.67 SIGMAR1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7381738-B2 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2008-06-03 US disclosed
US-7288563-B2 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2007-10-30 US disclosed
WO-2007066784-A2 DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-06-14 WO disclosed
US-7230022-B2 Substituted fused bicyclic amines as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-12 US disclosed
US-20050227960-A1 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY 2005-10-13 US disclosed
US-20050197373-A1 Substituted fused bicyclic amines as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY 2005-09-08 US disclosed
US-20050192276-A1 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY 2005-09-01 US disclosed